Navigation Links
Risk Of Decongestants In Hypertensive Patients

Having a stuffy nose can be unpleasant, but doctors say that discomfort is minor compared to the risk of taking over-the-counter decongestants if you have high blood pressure. Though they are generally safe, many popular cold and flu medicines contain decongestants such as pseudoephedrine and phenylephrine, which doctors say may aggravate blood pressure problems.//

And while products containing such ingredients are required to list such warnings on their labels, the warnings often go unnoticed or ignored by many who assume over-the-counter drugs are safe for one and all. One big reason such warnings may be ignored is because nearly half of the estimated 50 million people in the United States with high blood pressure don't even realize they have a problem.

"The warnings are very often ignored," says Dr. Lynn Smaha, past president of the American Heart Association. "But people who have a history of heart trouble or high blood pressure should be very careful in adhering to the warnings on the labels of these drugs."

The problem is that the active ingredients in many decongestants can't target the blood vessels in the nose. Instead, they constrict blood vessels throughout your body, and raise your blood pressure. If you already have high blood pressure, that can increase your risk for stroke or heart attack.

Furthermore, the decongestants can work against anti-hypertensive drugs that patients might take for their high blood pressure. There are over-the-counter cold and flu products that claim to be safe for people with high blood pressure, but according to Smaha, they're unlikely to help those looking for a decongestant.
'"/>




Page: 1

Related medicine news :

1. Hypertensive Drug Improves Sexual Dysfunction in Hypertensive Men
2. Hypertensive drugs may cause cough
3. Hypertensives could benefit regular alcohol consumption
4. Prehypertension in the Young Leads to Hypertensive Adults
5. Hypertensive Kids at risk of sleep disordered breathing
6. One in Three Heart Attack Patients Have No Chest Pains
7. Amphetamines Help Recovery of Stroke Patients
8. Painkillers Do Not Shorten Dying Patients Lives
9. Patients With Filariasis More Prone To HIV Infection
10. Glivec - New Hope For CMC Patients
11. Patients often assume wrongly that they are allergic to penicillin
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/27/2016)... ... 27, 2016 , ... Beleza Medspa has initiated a new program ... is the first time that Coolsculpting is being used for for more than just ... ensure they meet the prescribed body-fat standard, measured by the circumference-based tape method. ...
(Date:5/27/2016)... ... May 27, 2016 , ... With ... pharmaceutical, medical and food industries. Aside from its GMP accreditation, Validation Center is ... of successfully certified products, services and staff. , Validation Center is ISO17025 accredited ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... thousands of defective respirators, according to court documents and SEC filings. A ... and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, ...
(Date:5/26/2016)... Washington, D.C. (PRWEB) , ... May 26, 2016 , ... ... the men and women who lost their lives in military battle for the country. ... discount cards in 2015 to provide more programs that empower independence for disabled military ...
(Date:5/26/2016)... ... May 26, 2016 , ... MadgeTech will be showcasing its line of ... Warner, New Hampshire at the MadgeTech headquarters. With products sold in more than 100 ... government agencies, including NASA. , In 2012, NASA strategically set up 17 RHTemp101A ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... -- According to a new market research ... by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by Application (Drug ... Hospitals/ Clinics) - Forecast to 2021", published by MarketsandMarkets, ... the forecast period of 2016 to 2021. This market ... from USD 117.3 Million in 2016, at a CAGR ...
(Date:5/25/2016)... Germany and GERMANTOWN, Maryland ... N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: QIA) ... and co-development agreement with Therawis Diagnostics GmbH to develop and ... to develop and market PITX2 as a marker to predict ... breast cancer patients. "We are pleased to partner ...
(Date:5/25/2016)... , May 25, 2016  According to Kalorama ... $381 billion in 2015.  Though these are challenging ... of opportunity for success for companies that remain ... search of new growth prospects medical device companies ... research and development (R&D) than do companies in ...
Breaking Medicine Technology: